5-hydroxytryptamine inhibits pressor responses to preganglionic sympathetic nerve stimulation in pithed rats. 1995

C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
Terapéutica Experimental, CINVESTAV, I.P.N., México D.F., México.

5-Hydroxytryptamine (5-HT) inhibits contractile responses to adrenergic nerve stimulation in several blood vessels and organs. We have now investigated the potential ability of 5-HT to inhibit the pressor responses caused by preganglionic sympathetic stimulation (T7-T9) in pithed rats. Sympathetic stimulation (0.03, 0.1, 0.3, 1 and 3 Hz) resulted in frequency-dependent increases in diastolic blood pressure; these effects were augmented after i.v. treatment with desipramine (50 micrograms/kg). During continuous infusions of 5-HT (1.8, 3.1, 5.6 and 10 micrograms/kg.min, i.v.), but not of saline, the pressor responses were dose-dependently inhibited in both control and desipramine-pretreated rats; this inhibitory effect of 5-HT was significantly more pronounced at lower frequencies of stimulation. In contrast, the above infusions of 5-HT did not inhibit the pressor responses induced by i.v. bolus injections of exogenous norepinephrine (up to 3 micrograms/kg). Taken together, the above findings suggest an operative 5-HT-induced prejunctional inhibition of sympathetic nerve activity on the systemic vasculature in vivo.

UI MeSH Term Description Entries
D008297 Male Males
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D011311 Pressoreceptors Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls. Baroreceptors,Receptors, Stretch, Arterial,Receptors, Stretch, Vascular,Stretch Receptors, Arterial,Stretch Receptors, Vascular,Arterial Stretch Receptor,Arterial Stretch Receptors,Baroreceptor,Pressoreceptor,Receptor, Arterial Stretch,Receptor, Vascular Stretch,Receptors, Arterial Stretch,Receptors, Vascular Stretch,Stretch Receptor, Arterial,Stretch Receptor, Vascular,Vascular Stretch Receptor,Vascular Stretch Receptors
D003655 Decerebrate State A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358) Decerebrate Posturing,Decorticate Rigidity,Decorticate State,Rigidity, Decerebrate,Rigidity, Decorticate,Decerebrate Posturings,Decerebrate Rigidity,Decerebrate States,Decorticate Rigidities,Decorticate States,Posturing, Decerebrate,Posturings, Decerebrate,Rigidities, Decorticate,State, Decerebrate,States, Decerebrate
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001339 Autonomic Fibers, Preganglionic NERVE FIBERS which project from the central nervous system to AUTONOMIC GANGLIA. In the sympathetic division most preganglionic fibers originate with neurons in the intermediolateral column of the SPINAL CORD, exit via ventral roots from upper thoracic through lower lumbar segments, and project to the paravertebral ganglia; there they either terminate in SYNAPSES or continue through the SPLANCHNIC NERVES to the prevertebral ganglia. In the parasympathetic division the fibers originate in neurons of the BRAIN STEM and sacral spinal cord. In both divisions the principal transmitter is ACETYLCHOLINE but peptide cotransmitters may also be released. Autonomic Fiber, Preganglionic,Fiber, Preganglionic Autonomic,Fibers, Preganglionic Autonomic,Preganglionic Autonomic Fiber,Preganglionic Autonomic Fibers
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
January 1999, Life sciences,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
January 1996, Archives of medical research,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
December 1983, Journal of autonomic pharmacology,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
December 1994, British journal of pharmacology,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
January 2016, European journal of pharmacology,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
September 2010, European journal of pharmacology,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
January 1982, Clinical and experimental pharmacology & physiology. Supplement,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
May 2020, Archives of medical research,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
March 1984, Brain research,
C M Villalón, and J Contreras, and E Ramŕiez-San Juan, and C Castillo, and M Perusquía, and F J López-Muñoz, and J A Terrón
January 1988, The American journal of physiology,
Copied contents to your clipboard!